K Moeremans

Breast-cancer detection using blood-based infrared molecular fingerprints

The Economic Burden of Stroke in the United Kingdom

Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review

Kidney stones: pathophysiology and medical management

Recombinant Urate Oxidase (Rasburicase) in the Prophylaxis and Treatment of Tumor Lysis Syndrome

Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management

Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review

Point-of-care testing for patients with diabetes, hyperlipidaemia or coagulation disorders in the general practice setting: a systematic review

Oral Anticoagulant Therapy

Pathogen inactivation: making decisions about new technologies

Rasburicase: future directions in tumor lysis management

24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience

Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting

A predictive model for the detection of tumor lysis syndrome during AML induction therapy

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

Incidence and Pathogenesis of Tumor Lysis Syndrome

The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus

Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

The Tumor Lysis Syndrome

Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention

Computerized advice on drug dosage to improve prescribing practice

Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome

Assessment of Melamine and Cyanuric Acid Toxicity in Cats

Industry sponsorship and research outcome

Long-term medical costs of postmenopausal breast cancer therapy

Assessment of the economic value of the INTERCEPT blood system in Belgium

Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor?positive early breast cancer. Analysis based on the ATAC trial

Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients

Second Line Pharmacological Management of Paroxysmal and Persistent Atrial Fibrillation in France: A Cost Analysis

Incidence, Medical Resource Utilisation and Costs of Hyperuricemia and Tumour Lysis Syndrome in Patients with Acute Leukaemia and Non-Hodgkin's Lymphoma in Four European Countries

Estimating the Cost-Effectiveness of Quality-Improving Interventions in Oral Anticoagulation Management within General Practice

Modeling Costs and Cost-Effectiveness of Different CMV Management Strategies in Liver Transplant Recipients as a Support for Current and Future Decision Making